High dose chemotherapy with haematopoietic rescue in breast cancerBEZWODA, W. R.Hematology and cell therapy (Print). 1999, Vol 41, Num 2, pp 58-65, issn 1269-3286Conference Paper

c-erb-B₂ expression and response to treatment in metastatic breast cancerBEZWODA, W. R.Medical oncology (Northwood). 2000, Vol 17, Num 1, pp 22-28, issn 1357-0560Article

Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens : comparison of aminoglutethimide plus hdyrocortisone with mexdroxyprogesterone acetate plus hydrocortisoneBEZWODA, W. R.British journal of urology (Print). 1990, Vol 66, Num 2, pp 196-201, issn 0007-1331, 6 p.Article

In vitro maintenance of a new ovarian cancer cell line in protein-free media : a potential model for autonomous growth and tumor progressionGOLOMBICK, T; BEZWODA, W. R.European journal of cell biology. 1991, Vol 56, Num 2, pp 459-463, issn 0171-9335Article

Bisantrene in the treatment of relapsed acute non-lymphocyticBEZWODA, W. R; SEYMOUR, L.Bone marrow transplantation (Basingstoke). 1989, Vol 4, issn 0268-3369, p. 65, suppl. 3Conference Paper

Sequential α-interferon and tamoxifen : In vitro biologic effects of two growth modulatorsSEYMOUR, L; BEZWODA, W. R.International journal of oncology. 1997, Vol 10, Num 6, pp 1277-1282, issn 1019-6439Article

Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancerSEYMOUR, L; BEZWODA, W. R.Breast cancer research and treatment. 1994, Vol 32, Num 2, pp 229-233, issn 0167-6806Article

The use of mitoxantrone plus cyclophosphamide as first-line treatment of metastatic breast cancerBEZWODA, W. R; HESDORFFER, C.Cancer. 1986, Vol 58, Num 8, pp 1621-1624, issn 0008-543XArticle

Interferon plus tamoxifen treatment for advanced breast cancer : in vivo biologic effects of two growth modulatorsSEYMOUR, L; BEZWODA, W. R.British journal of cancer. 1993, Vol 68, Num 2, pp 352-356, issn 0007-0920Article

Isolation and characterisation of lactoferrin separated from human whey by adsorption chromatography using Cibacron Blue F3G-A linked affinity adsorbentBEZWODA, W. R; MANSOOR, N.Clinica chimica acta. 1986, Vol 157, Num 1, pp 89-93, issn 0009-8981Article

TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expressionAMOILS, K. D; BEZWODA, W. R.Breast cancer research and treatment. 1997, Vol 42, Num 2, pp 95-101, issn 0167-6806Article

High-dose etoposide in treatment of metastatic breast cancerBEZWODA, W. R; SEYMOUR, L; ARIAD, S et al.Oncology. 1992, Vol 49, Num 2, pp 104-107, issn 0030-2414Article

Response to second-line hormone treatment for advanced breast cancer : predictive value of ploidy determinationSEYMOUR, L; BEZWODA, W. R; MEYER, K et al.Cancer. 1990, Vol 65, Num 12, pp 2720-2724, issn 0008-543X, 5 p.Article

Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyura with cisdiamminedichloro-platinum plus methotrexateBEZWODA, W. R; NISSENBAUM, M; DERMAN, D. P et al.Medical and pediatric oncology. 1986, Vol 14, Num 1, pp 17-19, issn 0098-1532Article

Seizures after antiemetic treatment with high dose domperidone: report of four casesWEAVING, A; BEZWODA, W. R; DERMAN, D. P et al.British medical journal (1857). 1984, Vol 288, Num 6432, issn 0007-1447, 1728Article

Intraperitoneal recombinant interferon-alpha 2b for recurrent malignant ascites due to ovarian cancerBEZWODA, W. R; SEYMOUR, L; DANSEY, R et al.Cancer. 1989, Vol 64, Num 5, pp 1029-1033, issn 0008-543X, 5 p.Article

Neutrophil lactoferrin content in viral infectionsBAYNES, R. D; BEZWODA, W. R; NAZMA MANSOOR et al.American journal of clinical pathology. 1988, Vol 89, Num 2, pp 225-228, issn 0002-9173Article

In vitro assessment of melphalan induced cytotoxicity and interstrand-DNA-cross-links in lymphocytes from patients with lymphoproliferative disorders : Correlation and mechanisms of alkylator resistance in vitro and in vivoBEZWODA, W. R; PU, Q. Q.International journal of oncology. 1997, Vol 10, Num 5, pp 1061-1068, issn 1019-6439Article

Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancerSEYMOUR, L; DAJEE, D; BEZWODA, W. R et al.Breast cancer research and treatment. 1993, Vol 26, Num 3, pp 247-252, issn 0167-6806Article

Interferon (IFN) alpha inhibits cell proliferation of UWOV₂ cells without down-regulation of transferrin receptorsBEZWODA, W. R; GOLOMBICK, T; MANSOOR, N et al.Molecular biotherapy. 1991, Vol 3, Num 3, pp 124-126, issn 0952-8172Article

Interleukin-4 prevents spontaneous in-vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicityPU, Q. Q; BEZWODA, W. R.British journal of haematology. 1997, Vol 98, Num 2, pp 413-417, issn 0007-1048Article

P-glycoprotein immunostraining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced breast cancerSEYMOUR, L; BEZWODA, W. R; DANSEY, R. D et al.Breast cancer research and treatment. 1995, Vol 36, Num 1, pp 61-69, issn 0167-6806Article

A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-upBEZWODA, W. R; RASTOGI, R. B.Seminars in hematology. 1994, Vol 31, Num 2, issn 0037-1963, p. 3, SUP3Conference Paper

Kaposi's sarcoma after alpha-interferon treatment for HIV-negative T-cell lymphomaARIAD, S; LEWIS, D; BEZWODA, W. R et al.SAMJ. South African medical journal. 1993, Vol 83, Num 6, pp 430-431, issn 0256-9574Article

Plasma lactoferrin content and lactoferrin gene expression in acute leukaemiaBEZWODA, W. R; DAJEE, D; KEEPING, J et al.Bone marrow transplantation (Basingstoke). 1989, Vol 4, issn 0268-3369, p. 21, suppl. 3Conference Paper